N/A
Completed N=2,506
D-dimer Assay for the Exclusion of Intra-atrial Thrombus Risk Before Ablation of Atrial Fibrillation
Source: ClinicalTrials.gov NCT02199080 ↗Enrolled (actual)
2,506
Serious AEs
0.0%
Results posted
Feb 2019
Primary outcomePrimary: Number of Patients With Atrial Thrombus Diagnosed by Transoesophageal Ultrasound — 48 Participants
Summary
The purpose of this study is to determine whether D-dimer dosage allow to exclude risk of intraatrial thrombus before performing an ablation of atrial fibrillation
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Patients With Atrial Thrombus Diagnosed by Transoesophageal Ultrasound |
48 | — |
| SECONDARY CHADS2 Score |
5; 1277; 20; 744; 13; 299 | — |
| SECONDARY Risk Factors |
8; 148; 15; 661; 28; 968 | — |
| SECONDARY Atrial Thrombus Exclusion (ATE) Score |
0; 911; 23; 965; 14; 467 | — |
Eligibility Criteria
Inclusion Criteria
- Age> 18 years.
- Patients hospitalized for ablation of atrial fibrillation or symptomatic left flutter
- Patient informed of the study
Exclusion Criteria
- Age <18 years.
- Patients under guardianship
- Pregnant woman
- Contraindication to transesophageal echocardiography
- transesophageal echocardiography made in another center as the center of ablation
- Refusal of the patient to participate in the study
- Patient participating in another interventional study in which an intervention related to biomedical research is performed before the transesophageal echocardiography
Data sourced from ClinicalTrials.gov (NCT02199080). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.